Newsroom
All the news
Dr. Albert Quintana received the committed optimist in science award
The Anoche tuve un sueño magazine awarded Dr. Albert Quintana for his project to create a kit to detect antibiotic resistance.
Bosses d'ajut per assistir a congressos i reunions científiques (PhD en Neurociències)
Per contribuir en la formació dels/les estudiants del programa de PhD en Neurociències de l'INc-UAB, mitjançant l’assistència a congressos i reunions científiques on presentin el seu treball experimental, s'ha convocat una beca de viatges pel 2024.
INc-UAB Calçotada
The Neurodocs Student Association organized a calçotada last April 6, which brought together around 30 members of the Institute.
Activities for the Brain Awareness Week
The Brain Awareness Week is a global initiative to which the Institute joins every year to give visibility to the research that is done on this organ and the nervous system in general.
Collaboration with AdSalutem
The Institute has signed a collaboration agreement with AdSalutem, a reference center in sleep medicine and brain health. The idea of ¿¿the agreement is to promote collaborations between INc-UAB groups and professionals from the centre.
New therapeutic approaches for hypertension through TRPV2 proteins
Researchers at the Institute have carried out two revealing studies on TRPV2, a key ion channel in several cellular functions, which points to it as a possible new therapeutic target in the treatment of hypertension. On the one hand, they have discovered the vessel-dilating effects of its activation and, on the other, they have identified a molecule capable of activating it in a more potent way than the drugs known to date.
New animal model created to study Parkinson's disease before neurodegeneration appears
A research team led by Dr Esther Dalfó has managed to generate and validate a new animal model. This model enables the examination of the initial phases of Parkinson's disease, occurring prior to the onset of motor symptoms, and the exploration of molecular processes preceding neuronal degeneration. The new model, based on the Caenorhabditis elegans worm, emerges as an essential tool in creating future therapies aimed at stopping the characteristic loss of neuronal structure and function seen in the disease.
Anti-cancer drug could improve symptoms after stroke
A study coordinated by Dr. Jiménez-Altayó demonstrates in animal models the benefits of vorinostat after having suffered a stroke. The drug, used in humans to treat cutaneous T-cell lymphoma, has been proved to mitigate brain injuries and help in restoring brain tissue.
Interview to Dr. Paula Escudero
Dr. Paula Escudero did a postdoc at the laboratory coordinated by Dr. Jose Manuel López Blanco, with whom she has recently published an article on how the cell culture medium conditions influence the study of Lesch-Nyhan's neurological disease.
11F: Women and girls in Science Day
February the 11th is the International Day of Women and Girls in Science, and to celebrate it we're running activities in schools and high-schools.